The Ozempic Shortage Is Over
US$ 25.11
anthem glp-1 coverage blue cross BCBS Michigan Changes Obesity Medication Rules anthem blue cross glp 1
Description
The mixed reviews for GLP-1 Complete reflect this variability
Both companies anticipate continued growth for Dupixent, particularly as it gains traction in the COPD market and expands into additional indications
Apart from WEGOVY, SAXENDA , another Novo Nordisk weight loss drug, is also approved in the US for obesity
Walmart previously recorded stronger grocery sales when high inflation was driving wealthier shoppers to its stores
It likely comes as no surprise, then, that 12% of Americans indicate cost as the biggest obstacle to taking Ozempic or another GLP-1 medication
